- Benign Prostatic Hyperplasia
- Hormone Therapy
- Genomic Testing
- Next-Generation Imaging
- UTUC
- OAB and Incontinence
- Genitourinary Cancers
- Kidney Cancer
- Men's Health
- Pediatrics
- Female Urology
- Sexual Dysfunction
- Kidney Stones
- Urologic Surgery
- Bladder Cancer
- Benign Conditions
- Prostate Cancer
Aquablation preserves antegrade ejaculation in men with large prostate glands
“The majority of treatments out there don't allow the maintenance of ejaculation after surgery, whereas here, we're at 90% for the small glands…[and at] 81% [for] the men who had prostates above 80 grams,” says Naeem Bhojani, MD, FRCSC.
In this video, Naeem Bhojani, MD, FRCSC, and David-Dan Nguyen discuss the background and findings of the study, “WATER vs WATER II: Three Year Comparison of Aquablation Therapy for Benign Prostatic Hyperplasia,” presented at the 2021 American Urological Association Annual Meeting. Bhojani is a urologist at CHUM Research Centre and an associate professor in the departments of surgery and social and preventative medicine at the University of Montreal, and Nguyen is a medical student at McGill University, Montreal, Quebec, Canada.
Academic, private practice urologists collaborate to change BPH reimbursement
April 1st 2024"We really aimed to affect 3 different contraindications and instead achieved retirement of the entire policy, which, we think, really opens up this wonderful technology to literally hundreds of thousands more patients across the country," says Arpeet Shah, MD.
